Standout Papers

Infliximab, Azathioprine, or Combination Thera... 1994 2026 2004 2015 2.2k
  1. Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease (2010)
    Jean‐Frédéric Colombel, William J. Sandborn et al. New England Journal of Medicine
  2. Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy (1994)
    Simon Lichtiger, D. H. Present et al. New England Journal of Medicine
  3. Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease (2012)
    William J. Sandborn, Christopher Gasink et al. New England Journal of Medicine
  4. Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment (2016)
    Jordan E. Axelrad, Simon Lichtiger et al. World Journal of Gastroenterology

Immediate Impact

2 by Nobel laureates 13 from Science/Nature 137 standout
Sub-graph 1 of 14

Citing Papers

Crohn's disease
2024 Standout
Ulcerative colitis
2023 Standout
79 intermediate papers

Works of Simon Lichtiger being referenced

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy
1994 Standout
and 17 more

Author Peers

Author Last Decade Papers Cites
Simon Lichtiger 5250 4075 2000 63 6.8k
Walter Reinisch 5160 3977 1964 69 6.9k
Jean–Frédéric Colombel 6753 5320 2615 69 8.6k
Robert H. Diamond 5617 4877 1990 56 8.0k
A. Hillary Steinhart 6438 5025 2262 144 8.3k
Catherine Milch 4627 3633 1400 61 6.0k
Ebbe Langholz 5687 4377 2829 97 7.6k
Serap Sankoh 4654 3673 1481 67 6.5k
Ian Arnott 3957 2996 1855 126 5.3k
Jean‐Louis Dupas 3459 2980 1944 109 5.3k
Lloyd R. Sutherland 6319 5316 3006 86 9.0k

All Works

Loading papers...

Rankless by CCL
2026